IA e reconhecimento facial detectam derrame e outras doenças; entenda

 10/04/2023 

Olhar Digital

“La empresa de biotecnología FDNA ha desarrollado un software que tiene como objetivo utilizar el reconocimiento facial para diagnosticar enfermedades genéticas raras en niños pequeños. La plataforma Face2Gene permite a un médico subir escaneos de la cara de un paciente a una aplicación y obtener recomendaciones sobre si la imagen puede indicar una de las 1.500 afecciones o síndromes asociados con los rasgos faciales. La plataforma cuenta con 47 mil usuarios, entre genetistas, neurólogos, pediatras e investigadores.”

 

The article from Olhar Digital describes that FDNA is leveraging facial recognition AI to detect strokes and other diseases. This innovative technology, Face2Gene, analyzes patient photos using advanced algorithms to identify facial features linked to various medical conditions. By comparing these features to a vast database, Face2Gene offers rapid and accurate diagnostic suggestions. This approach enhances early detection and timely intervention, which are crucial for conditions like strokes.

Related articles

AI in genetic diagnosis

The Evolution of FDNA’s technology: An Interview with Aviram Bar Haim

Analyzing facial features has long been a vital step in diagnosing genetic syndromes. In recent years, AI-driven technologies have transformed this process, making it more efficient and accurate. Leading this innovation is Face2Gene, an advanced AI platform that leverages machine learning to assist clinicians in identifying genetic disorders. To explore the development of this groundbreaking […]

Continue reading
Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading